These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9877025)

  • 1. Cytogenetics of benign breast lesions.
    Lundin C; Mertens F
    Breast Cancer Res Treat; 1998 Sep; 51(1):1-15. PubMed ID: 9877025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic changes in benign proliferative and nonproliferative lesions of the breast.
    Lundin CP; Mertens F; Rizou H; Idvall I; Georgiou G; Ingvar C; Pandis N
    Cancer Genet Cytogenet; 1998 Dec; 107(2):118-20. PubMed ID: 9844605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue.
    Dietrich CU; Pandis N; Teixeira MR; Bardi G; Gerdes AM; Andersen JA; Heim S
    Int J Cancer; 1995 Jan; 60(1):49-53. PubMed ID: 7814151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aneuploidy in proliferative breast disease.
    Micale MA; Visscher DW; Gulino SE; Wolman SR
    Hum Pathol; 1994 Jan; 25(1):29-35. PubMed ID: 8314258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic findings in phyllodes tumors of the breast: karyotypic complexity differentiates between malignant and benign tumors.
    Dietrich CU; Pandis N; Rizou H; Petersson C; Bardi G; Qvist H; Apostolikas N; Bøhler PJ; Andersen JA; Idvall I; Mitelman F; Heim S
    Hum Pathol; 1997 Dec; 28(12):1379-82. PubMed ID: 9416694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of epithelial hyperplasias of the human breast.
    Burbano RR; Medeiros A; de Amorim MI; Lima EM; Mello A; Neto JB; Casartelli C
    Cancer Genet Cytogenet; 2000 May; 119(1):62-6. PubMed ID: 10812173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of fibrocystic breast disease with polysomy 18 as the sole clonal cytogenetic abnormality.
    Staats B; Bonk U; Gohla G; Bartnitzke S; Bullerdiek J
    Cancer Genet Cytogenet; 1998 Jun; 103(2):91-4. PubMed ID: 9614905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in benign breast tissue.
    Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
    J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic changes in nonmalignant breast tissue.
    Steinarsdóttir M; Jónasson JG; Vidarsson H; Júlíusdóttir H; Hauksdóttir H; Ogmundsdóttir HM
    Genes Chromosomes Cancer; 2004 Sep; 41(1):47-55. PubMed ID: 15236316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families.
    Petersson C; Pandis N; Mertens F; Adeyinka A; Ingvar C; Ringberg A; Idvall I; Bondeson L; Borg A; Olsson H; Kristoffersson U; Mitelman F
    Genes Chromosomes Cancer; 1996 Jul; 16(3):185-8. PubMed ID: 8814451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenograft model of progressive human proliferative breast disease.
    Miller FR; Soule HD; Tait L; Pauley RJ; Wolman SR; Dawson PJ; Heppner GH
    J Natl Cancer Inst; 1993 Nov; 85(21):1725-32. PubMed ID: 8411256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsy study of radial scar in the female breast.
    Nielsen M; Jensen J; Andersen JA
    Histopathology; 1985 Mar; 9(3):287-95. PubMed ID: 3997086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign breast lesions in Bayelsa State, Niger Delta Nigeria: a 5 year multicentre histopathological audit.
    Uwaezuoke SC; Udoye EP
    Pan Afr Med J; 2014; 19():394. PubMed ID: 25995790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
    Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
    Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign breast lesions.
    Ajao OG
    J Natl Med Assoc; 1979 Sep; 71(9):867-8. PubMed ID: 501753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China.
    Shannon J; King IB; Lampe JW; Gao DL; Ray RM; Lin MG; Stalsberg H; Thomas DB
    Am J Clin Nutr; 2009 Jan; 89(1):265-76. PubMed ID: 19056601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign breast disease and cancer risk.
    Bianchi S; Palli D; Galli M; Zampi G
    Crit Rev Oncol Hematol; 1993 Dec; 15(3):221-42. PubMed ID: 8142058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.